ΔNp63 antagonizes p53 to regulate mesoderm induction in Xenopus laevis

Developmental Biology

Volumn 329, Issue 1, 2009, Pages 130-139

  Barton, Christopher E ^a,b   Tahinci, Emilios ^a,b   Barbieri, Christopher E ^a,b   Johnson, Kimberly N ^a,b   Hanson, Alison J ^a,b   Jernigan, Kristin K ^a,b   Chen, Tony W ^a,b   Lee, Ethan ^a,b   Pietenpol, Jennifer A ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

Activin A; Differentiation; EMT; Mesoderm; p53; p63; Xenopus

Indexed keywords

ACTIVIN A; PROTEIN P53; PROTEIN P63; ACTIVIN; ANTISENSE OLIGONUCLEOTIDE; PHOSPHOPROTEIN; SMALL INTERFERING RNA; TP63 PROTEIN, HUMAN; TP73L PROTEIN, XENOPUS; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; XENOPUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL FATE; CELL MATURATION; CONTROLLED STUDY; DOWN REGULATION; ECTODERM; EMBRYO; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; KERATINOCYTE; MESODERM; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SQUAMOUS EPITHELIUM; XENOPUS LAEVIS; ANIMAL; ANIMAL EMBRYO; BIOLOGICAL MODEL; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; PRENATAL DEVELOPMENT; TUMOR CELL LINE;

XENOPUS LAEVIS;

ACTIVINS; ANIMALS; CELL LINE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EMBRYO, NONMAMMALIAN; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MESODERM; MODELS, BIOLOGICAL; OLIGONUCLEOTIDES, ANTISENSE; ORGAN CULTURE TECHNIQUES; PHOSPHOPROTEINS; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; XENOPUS LAEVIS; XENOPUS PROTEINS;

EID: 64049116039     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2009.02.036     Document Type: Article

References (61)

1. Agius E., Oelgeschlager M., Wessely O., Kemp C., and De Robertis E.M. Endodermal Nodal-related signals and mesoderm induction in Xenopus. Development 127 (2000) 1173-1183
2. Augustin M., Bamberger C., Paul D., and Schmale H. Cloning and chromosomal mapping of the human p53-related KET gene to chromosome 3q27 and its murine homolog Ket to mouse chromosome 16. Mamm. Genome 9 (1998) 899-902
3. Bakkers J., Hild M., Kramer C., Furutani-Seiki M., and Hammerschmidt M. Zebrafish DeltaNp63 is a direct target of Bmp signaling and encodes a transcriptional repressor blocking neural specification in the ventral ectoderm. Dev. Cell 2 (2002) 617-627
4. Bakkers J., Hild M., Kramer C., Furutani-Seiki M., and Hammerschmidt M. Zebrafish DeltaNp63 is a direct target of Bmp signaling and encodes a transcriptional repressor blocking neural specification in the ventral ectoderm. Dev. Cell 2 (2002) 617-627
5. Barbieri C.E., Barton C.E., and Pietenpol J.A. Delta Np63 alpha expression is regulated by the phosphoinositide 3-kinase pathway. J. Biol. Chem. 278 (2003) 51408-51414
6. Barbieri C.E., Perez C.A., Johnson K.N., Ely K.A., Billheimer D., and Pietenpol J.A. IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium. Cancer Res. 65 (2005) 2314-2320
7. Barbieri C.E., Tang L.J., Brown K.A., and Pietenpol J.A. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res. 66 (2006) 7589-7597
8. Birkaya B., Ortt K., and Sinha S. Novel in vivo targets of DeltaNp63 in keratinocytes identified by a modified chromatin immunoprecipitation approach. BMC Mol. Biol. 8 (2007) 43
9. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
10. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
11. Brunner H.G., Hamel B.C., and Van Bokhoven H. The p63 gene in EEC and other syndromes. J. Med. Genet. 39 (2002) 377-381
12. Chang H., Brown C.W., and Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 23 (2002) 787-823
13. Cordenonsi M., Dupont S., Maretto S., Insinga A., Imbriano C., and Piccolo S. Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113 (2003) 301-314
14. Dellavalle R.P., Egbert T.B., Marchbank A., Su L.J., Lee L.A., and Walsh P. CUSP/p63 expression in rat and human tissues. J. Dermatol. Sci. 27 (2001) 82-87
15. Di Como C.J., Urist M.J., Babayan I., Drobnjak M., Hedvat C.V., Teruya-Feldstein J., Pohar K., Hoos A., and Cordon-Cardo C. p63 expression profiles in human normal and tumor tissues. Clin. Cancer Res. 8 (2002) 494-501
16. Flatt P.M., Tang L.J., Scatena C.D., Szak S.T., and Pietenpol J.A. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent. Mol. Cell. Biol. 20 (2000) 4210-4223
17. Harland R.M. In situ hybridization: an improved whole mount method for Xenopus embryos. In: Kay B.K., and Peng H.B. (Eds). Xenopus laevis: Practical Uses in Cell and Molecular Biology vol. 36 (1991), Academic Press, San Diego 685-695
18. Harms K., Nozell S., and Chen X. The common and distinct target genes of the p53 family transcription factors. Cell. Mol. Life Sci. 61 (2004) 822-842
19. Ho J., deGuise C., Kim C., Lemay S., Wang X.F., and LeBrun J.J. Activin induces hepatocyte cell growth arrest through induction of the cyclin-dependent kinase inhibitor p15INK4B and Sp1. Cell. Signal 16 (2004) 693-701
20. Ito Y., Sarkar P., Mi Q., Wu N., Bringas Jr. P., Liu Y., Reddy S., Maxson R., Deng C., and Chai Y. Overexpression of Smad2 reveals its concerted action with Smad4 in regulating TGF-beta-mediated epidermal homeostasis. Dev. Biol. 236 (2001) 181-194
21. Jones C.M., Kuehn M.R., Hogan B.L., Smith J.C., and Wright C.V. Nodal-related signals induce axial mesoderm and dorsalize mesoderm during gastrulation. Development 121 (1995) 3651-3662
22. Kimelman D. Mesoderm induction: from caps to chips. Nat. Rev., Genet. 7 (2006) 360-372
23. Kintner C.R., and Brockes J.P. Monoclonal antibodies identify blastemal cells derived from dedifferentiating limb regeneration. Nature 308 (1984) 67-69
24. Koster M.I., Kim S., Mills A.A., DeMayo F.J., and Roop D.R. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 18 (2004) 126-131
25. Koster M.I., Dai D., Marinari B., Sano Y., Costanzo A., Karin M., and Roop D.R. p63 induces key target genes required for epidermal morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 3255-3260
26. Lane M.C., and Keller R. Microtubule disruption reveals that Spemann's organizer is subdivided into two domains by the vegetal alignment zone. Development 124 (1997) 895-906
27. Lee H., and Kimelman D. A dominant-negative form of p63 is required for epidermal proliferation in zebrafish. Dev. Cell 2 (2002) 607-616
28. Lee H., and Kimelman D. A dominant-negative form of p63 is required for epidermal proliferation in zebrafish. Dev. Cell 2 (2002) 607-616
29. Lu P., Barad M., and Vize P.D. Xenopus p63 expression in early ectoderm and neurectoderm. Mech. Dev. 102 (2001) 275-278
30. Luo T., Matsuo-Takasaki M., and Sargent T.D. Distinct roles for Distal-less genes Dlx3 and Dlx5 in regulating ectodermal development in Xenopus. Mol. Reprod. Dev. 60 (2001) 331-337
31. Mills A.A., Zheng B.H., Wang X.J., Vogel H., Roop D.R., and Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398 (1999) 708-713
32. Munz B., Smola H., Engelhardt F., Bleuel K., Brauchle M., Lein I., Evans L.W., Huylebroeck D., Balling R., and Werner S. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J. 18 (1999) 5205-5215
33. Newport J., and Kirschner M. A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription. Cell 30 (1982) 687-696
34. Nieuwkoop P.D., and Faber J. Normal Table of Xenopus laevis (Daudin). 2nd ed (1967), North Holland Publishing Company, Amsterdam
35. Noszczyk B.H., and Majewski S.T. p63 expression during normal cutaneous wound healing in humans. Plast. Reconstr. Surg. 108 (2001) 1242-1247 discussion 1248-50
36. Osada M., Ohba M., Kawahara C., Ishioka C., Kanamaru R., Katoh I., Ikawa Y., Nimura Y., Nakagawara A., Obinata M., and Ikawa S. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med. 4 (1998) 839-843
37. Osada M., Park H.L., Nagakawa Y., Yamashita K., Fomenkov A., Kim M.S., Wu G., Nomoto S., Trink B., and Sidransky D. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol. Cell. Biol. 25 (2005) 6077-6089
38. Pellegrini G., Dellambra E., Golisano O., Martinelli E., Fantozzi I., Bondanza S., Ponzin D., McKeon F., and De Luca M. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. 98 (2001) 3156-3161
39. Perez C.A., Ott J., Mays D.J., and Pietenpol J.A. p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm. Oncogene 26 (2007) 7363-7370
40. Piepenburg O., Grimmer D., Williams P.H., and Smith J.C. Activin redux: specification of mesodermal pattern in Xenopus by graded concentrations of endogenous activin B. Development 131 (2004) 4977-4986
41. Ramis J.M., Collart C., and Smith J.C. Xnrs and activin regulate distinct genes during Xenopus development: activin regulates cell division. PLoS ONE 14 (2007) e213
42. Sanes J.R., Rubenstein J.L., and Nicolas J.F. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 5 (1986) 3133-3142
43. Sasai N., Yakura R., Kamiya D., Nakazawa Y., and Sasai Y. Ectodermal factor restricts mesoderm differentiation by inhibiting p53. Cell 133 (2008) 878-890
44. Senoo M., Pinto F., Crum C.P., and McKeon F. p63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129 (2007) 523-536
45. Smith J.C., Price B.M., Van Nimmen K., and Huylebroeck D. Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature 345 (1990) 729-731
46. Smith J.C., Price B.M.J., Green J.B.A., Weigel D., and Herrmann B.G. Expression of a Xenopus homolog of Brachyury (T) is an immediate-early response to mesoderm induction. Cell 67 (1991) 79-87
47. Sulyok S., Wankell M., Alzheimer C., and Werner S. Activin: an important regulator of wound repair, fibrosis, and neuroprotection. Mol. Cell. Endocrinol. 225 (2004) 127-132
48. Symes K., and Smith J.C. Gastrulation movements provide an early marker of mesoderm induction in Xenopus laevis. Development 101 (1987) 339-349
49. Szak S.T., Mays D., and Pietenpol J.A. Kinetics of p53 binding to promoter sites in vivo. Mol. Cell. Biol. 21 (2001) 3375-3386
50. Tahinci E., Thorne C.A., Franklin J.L., Salic A., Christian K.M., Lee L.A., Coffey R.J., and Lee E. Lrp6 is required for convergent extension during Xenopus gastrulation. Development 134 (2007) 4095-4106
51. Takebayashi-Suzuki K., Funami J., Tokumori D., Saito A., Watabe T., Miyazono K., Kanda A., and Suzuki A. Interplay between the tumor suppressor p53 and TGF beta signaling shapes embryonic body axes in Xenopus. Development 130 (2003) 3929-3939
52. Truong A.B., Kretz M., Ridky T.W., Kimmel R., and Khavari P.A. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev. 20 (2006) 3185-3197
53. Tsang M., Kim R., deCaestecker M.P., Kudoh T., Roberts A.B., and Dawid I.B. Zebrafish nma is involved in TGFbeta family signaling. Genesis 28 (2000) 47-57
54. Vigano M.A., Lamartine J., Testoni B., Merico D., Alotto D., Castagnoli C., Robert A., Candi E., Melino G., Gidrol X., and Mantovani R. New p63 targets in keratinocytes identified by a genome-wide approach. EMBO J. 25 (2006) 5105-5116
55. Vize P.D. DNA sequences mediating the transcriptional response of the Mix.2 homeobox gene to mesoderm induction. Dev. Biol. 177 (1996) 226-231
56. Westfall M.D., Mays D.J., Sniezek J.C., and Pietenpol J.A. The ΔNp63 alpha phosphoprotein binds the p21 and 14-3-3s promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell. Biol. 23 (2003) 2264-2276
57. Yang A., and McKeon F. P63 and P73: P53 mimics, menaces and more. Nat. Rev. Mol. Cell Biol. 1 (2000) 199-207
58. Yang A., Kaghad M., Wang Y., Gillet E., Fleming M., Dotsch V., Andrews N., Caput D., and McKeon F. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell. 2 (1998) 305-316
59. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R., Tabin C., Sharpe A., Caput D., Crum C., and McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398 (1999) 714-718
60. Yi R., Poy M.N., Stoffel M., and Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452 (2008) 225-229
61. Ying H., Chang D.L., Zheng H., McKeon F., and Xiao Z.X. DNA-binding and transactivation activities are essential for TAp63 protein degradation. Mol. Cell. Biol. 25 (2005) 6154-6164